| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/13/2001 | EP1105130A2 Heterocyclic esters or amides for vision and memory disorders |
| 06/13/2001 | EP1105126A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/13/2001 | EP1105125A2 Use of sulfonamides for treating vision and memory disorders |
| 06/13/2001 | EP1105124A2 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 06/13/2001 | CN1299346A Ureas and carbamates of N-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 06/13/2001 | CN1067057C Serotonin 5-HI1A and dopamin D2 receptor ligands |
| 06/13/2001 | CN1067055C Separation of enantiomers of amlodiping via their diastereomeric tartrates |
| 06/12/2001 | US6245911 Donepezil polycrystals and process for producing the same |
| 06/12/2001 | US6245809 Integrin antagonists |
| 06/12/2001 | CA2003388C Neuroprotective pharmaceutical compositions containing arylcyclohexylamines |
| 06/10/2001 | CA2327944A1 Process for preparing 1,4-dihydropyridine compounds |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040319A2 Inhibition of polymerization of unsaturated monomers |
| 06/07/2001 | WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/07/2001 | WO2001040184A2 Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation |
| 06/07/2001 | CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/06/2001 | EP1104754A1 Novel sulfonyl derivatives |
| 06/06/2001 | EP1104413A2 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104402A1 Pipecolic acid derivatives and their use for vision and memory disorders |
| 06/06/2001 | EP1104299A2 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 06/06/2001 | EP1104298A2 Heterocyclic thioesters or ketones for vision and memory disorders |
| 06/06/2001 | EP0873329B1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 06/06/2001 | CN1298399A Substituted alxoxycarbonyl compounds |
| 06/06/2001 | CN1298391A 1-[(1-substituted-4-piperidinyl) methyl]-4-piperidine derivatives, process for producing the same medicinal compositions containing the same and intermediate of these compounds |
| 06/06/2001 | CN1298389A Cyclic amino compounds |
| 06/06/2001 | CN1298299A Antibacterial agents |
| 06/06/2001 | CN1066712C Prolineamide derivatives |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242607 Such as 4-cyano-4-(3,4-dichlorophenyl)heptanedioic acid used as antagonists of neurokinines |
| 06/05/2001 | US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid |
| 06/05/2001 | US6242495 Compounds and compositions for delivering active agents |
| 06/05/2001 | US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents |
| 06/05/2001 | US6242466 Anticoagulants, antitumor, antimetastasis, anticarcinogenic, and antiinflammatory agents; bone disorders |
| 06/05/2001 | US6242465 Mixture with fungicide, viricide, bactericide, antitumor agent, antihistamine, and/or serotonin reuptake inhibitor; nervous system and psychological disorders; antiemetics |
| 06/05/2001 | US6242464 Resolving agent selected from the group consisting of d- and l-o-o'-ditoluoyltartaric acid |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 05/31/2001 | WO2001038304A1 Heterocyclic ketone and thioester compounds and uses |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | WO2000075172A3 Factor viia inhibitors |
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | CA2391575A1 Heterocyclic ketone and thioester compounds and uses |
| 05/30/2001 | EP1103552A1 Benzothiepin derivatives, process for the preparation of the same and uses thereof |
| 05/30/2001 | EP1103544A2 Piperidine derivatives and antiplatelet agents containing the same |
| 05/30/2001 | EP1102766A1 Triazolopyridines for the treatment of thrombosis disorders |
| 05/30/2001 | EP1102762A2 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 05/30/2001 | EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 05/30/2001 | EP1102747A1 Crystalline forms of osanetant |
| 05/30/2001 | EP1102746A1 Substituted phenylamidines with antithrombotic action |
| 05/30/2001 | EP1102743A1 Amide derivatives which are useful as cytokine inhibitors |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP1089974A4 Process to prepare dihydropyridine and derivatives thereof |
| 05/30/2001 | EP0842153B1 Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1r,5s,2"r)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphane |
| 05/30/2001 | EP0641320B1 Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists |
| 05/30/2001 | CN1297440A Piperidinyl and N-amidinopiperidinyl derivs. |
| 05/30/2001 | CN1066445C Aroyl-piperidine derivs. |
| 05/30/2001 | CN1066444C Nitrogenous derivs. for elemene and their use as anticancer drugs |
| 05/29/2001 | US6239306 Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulations |
| 05/29/2001 | US6239179 N-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| 05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 05/29/2001 | US6239155 Phenyl-substituted 1,4-dihydropyridines |
| 05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
| 05/29/2001 | US6239148 Treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a role by eliciting neurogenic pain, insulin resistance in diabetes mellitus or aging, inhibit insulin antagonizing peptide, |
| 05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
| 05/29/2001 | US6239146 Neurotrophic difluoroamide agents |
| 05/29/2001 | US6239145 Usable in acquiring information about active oxygen or in vivo free radicals as biological images such as magnetic resonance images or magnetoencephalograms; |
| 05/29/2001 | US6239126 Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives |
| 05/29/2001 | CA2195923C Azetidines |
| 05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
| 05/25/2001 | WO2001036385A1 Hydroxyethoxybenzamide derivatives and drugs containing the same |
| 05/25/2001 | WO2001036374A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 05/25/2001 | WO2001036360A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 05/25/2001 | WO2001029032A8 Process for the preparation of paroxetine |
| 05/25/2001 | WO2000077027A3 Serine protease inhibitors |
| 05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/24/2001 | US20010001799 Anticoagulant |
| 05/23/2001 | EP1101757A1 Heterocyclic compounds as tachykinin receptor antagonists |
| 05/23/2001 | EP1101755A1 Anthranilic acid derivatives |
| 05/23/2001 | EP1100782A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof |
| 05/23/2001 | EP1100781A1 High affinity ligands for nociceptin receptor orl-1 |
| 05/23/2001 | EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100502A1 Methods and compositions for treating gastro-esophageal reflux disease |
| 05/23/2001 | EP1100498A1 Heterocyclic sulphonamide derivatives |
| 05/23/2001 | EP1100497A1 Heterocyclyl sulphonamide derivatives |
| 05/23/2001 | EP1100495A1 Propenamides as ccr5 modulators |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | EP0689536B1 Naphthalene derivatives |
| 05/23/2001 | DE19955476A1 Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Bis-basic compounds as tryptase inhibitors, to processes for their preparation and their use as medicaments |
| 05/23/2001 | CN1296478A Histamine H3 receptor ligands |
| 05/23/2001 | CN1066168C Enhancing the storage stability of organic phosphites and phosphonites |
| 05/22/2001 | US6235934 Aqueous hexasubstituted guanidinium chlorides and methods for their preparation and use |
| 05/22/2001 | US6235927 Process for the separation of a mixture of enantiomers |
| 05/22/2001 | US6235791 Using cis n-cyclohexyl-n-ethyl(3-(3-chloro-cyclohexylphenyl)allyl)amine |